Zimbabwe has declined a significant US healthcare agreement worth 367 million US dollars (£272m) over five years due to Washington's request for sensitive biological samples.
The decision came to light following a government memo dated December was disclosed, revealing that Head of State Emmerson Mnangagwa believed the agreement was "unbalanced".
A government spokesman has since clarified that the US was demanding access to health data for scientific study and commercial purposes while was not willing to guarantee the benefits from future vaccines.
"We will now turn to the challenging and unfortunate task of winding down our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the United States had donated more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has appealed for more dialogue to find a deal agreeable to all parties so the country's vital HIV programme can continue.
Wider Implications
This rejection comes after a similar case in Kenya, where a court blocked a related deal with the US following concerns were filed about the security of citizens' health data.
After resuming office recently, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).
USAID had administered assistance for the American government, but Trump claimed its expenditure was "wasteful" and his government was seeking government-to-government agreements to enhance openness and accountability.
According to reports, 16 African countries have so far signed these new agreements, representing over $18.3bn in new funding.
Details of the Declined Deal
This assistance for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this cooperation could have provided extraordinary advantages for the people of Zimbabwe, especially the 1.2 million men, women and children currently on HIV treatment through US-supported programmes," Tremont added.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"Our nation was requested to share its biological resources and data for a long time, without any corresponding assurance of access to any medical innovations – like vaccines, diagnostics, or treatments – that could be developed from that provided information," Mangwana explained.
"Put simply, our country would provide the basic resources for scientific discovery without any assurance that the resulting innovations would be available to our people should a future pandemic arise."
National Interest and International Frameworks
Mangwana further noted that the American exit from the global health body and its pursuit of one-on-one deals were upending systems previously established through the global organization.
The spokesperson cited its Pandemic Benefit-Sharing scheme created to manage future pandemics.
"This mechanism is intended to ensure that when a nation provides its information, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the funds to develop them."
Zimbabwe's reservations over the US deal "are not meant as hostility towards the US," he added.
"We welcome ongoing dialogue with our US partners on how subsequent co-operation could be structured in a manner that honours the sovereignty and dignity of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but recommended that negotiations need to persist given that a large portion of the country's HIV programmes depended on external financing.
"If technical issues arise, including those involving data governance or implementation frameworks, these can frequently be addressed via detailed discussion and negotiated safeguards," it said.
This impasse highlights the ongoing challenges between accepting crucial international aid and protecting a country's data in an ever more interconnected world.